Literature DB >> 28251497

Why do patients with thick melanoma have different outcomes? A retrospective epidemiological and survival analysis.

E Rodríguez-Lomba1, I Marquez-Rodas2, E Mercader-Cidoncha3, R Suárez-Fernández4, J A Avilés-Izquierdo4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28251497     DOI： 10.1007/s12094-017-1637-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  5 in total

1.  Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain.

Authors:  José Antonio Avilés-Izquierdo; Pablo Lázaro-Ochaita
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

2.  Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma.

Authors:  José Antonio Avilés-Izquierdo; Irene Molina-López; Enrique Rodríguez-Lomba; Ivan Marquez-Rodas; Ricardo Suarez-Fernandez; Pablo Lazaro-Ochaita
Journal:  J Am Acad Dermatol       Date:  2016-09-16       Impact factor: 11.527

3.  The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.

Authors:  Danielle M Bello; Gang Han; Laura Jackson; Kaleigh Bulloch; Stephan Ariyan; Deepak Narayan; Bonnie Gould Rothberg; Dale Han
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

4.  Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France.

Authors:  Florent Grange; Coralie Barbe; Francois Aubin; Dan Lipsker; Florence Granel-Brocard; Michel Velten; Sophie Dalac; François Truchetet; Catherine Michel; Audrey Mitschler; Gwendoline Arnoult; Antoine Buemi; Stéphane Dalle; Philippe Bernard; Anne-Sophie Woronoff
Journal:  Arch Dermatol       Date:  2012-12

5.  Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.

Authors:  Arjen Joosse; Sandra Collette; Stefan Suciu; Tamar Nijsten; Poulam M Patel; Ulrich Keilholz; Alexander M M Eggermont; Jan Willem W Coebergh; Esther de Vries
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544
  5 in total
  1 in total

1.  Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma.

Authors:  Juan Carlos Rodriguez Otero; Maria Susana Dagatti; Ramon Fernandez Bussy; Adriana Bergero; Mario Gorosito; Roberto Staffieri; Roberto Villavicencio; Stella Maris Batalles; Stella Maris Pezzotto
Journal:  World J Oncol       Date:  2019-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.